JPET #104455

INTRODUCTION
Myocardial infarction (MI) evokes changes within the architecture of the left ventricular (LV) wall leading to chamber dilation. This process, which is termed post-MI remodeling, has been shown to be an independent predictor of morbidity and mortality in several large clinical trials. Thus, identifying and interrupting cellular and molecular pathways which contribute to LV structural remodeling post-MI hold significant clinical and scientific interest. While the LV remodeling process evokes changes within both the cellular and extracellular compartment, recent studies have demonstrated that changes in extracellular structure and composition occur within the MI region as well as surviving myocardium. (Frangogiannis et al., 2002; Schellings et al., 2004; Thompson and Squire, 2002; Wainwright, 2004) Specifically, the induction and activation of a family of matrix proteases, termed the matrix metalloproteinases (MMPs) have been demonstrated to occur in patients and animal models of myocardial injury and remodeling. (Bradham et al., 2002; Creemers et al., 2001; Kaden et al., 2003; Nian et al., 2004; Mukherjee et al., 2003; Tziakas et al., 2004; Wainwright, 2004; Yarbrough et al., 2003) The MMPs are a large family of proteolytic enzymes and can degrade a number of matrix proteins, process biologically active signaling molecules and growth factors, and degrade a number of transmembrane proteins. (Brinckerhoff and Matrisian, 2002; Coussens et al., 2002; McCawley and Matrisian, 2001; McDonnell et al., 1999; Overall et al., 2004; Steffensen et al., 2001; Tsuruda et al., 2004; Woessner, 1998) Utilizing murine transgenic constructs, genetic deletion of a specific MMP type can favorably modify the post-MI remodeling process whereas deletion of endogenous inhibitors of MMPs (TIMPs) can accelerate adverse JPET #104455 MMPs in the remodeling process, it is likely that a pharmacological MMP inhibition will be the approach to be considered in clinical application.
However, several outstanding issues regarding the utility of pharmacological MMP inhibition exist. First, initial clinical studies demonstrated adverse systemic side effects with prolonged MMP inhibition. (Bloomston et al., 2002; Coussens et al., 2002; Overall and Lopez-Otin, 2002; Vihinen and Kahari, 2002) Therefore, the duration of treatment with MMP inhibition following MI must be considered. Second, the effects of long term MMP inhibition on LV myocardial structure and function post-MI have not been examined.
Finally, while past studies have demonstrated a favorable effect of MMP inhibition on LV structure and function in animal models of MI, these have been of short duration. (Creemers et al., 2000; Creemers et al., 2001; Ikonomidis et al., 2005; Mukherjee et al., 2003; Yarbrough et al., 2003) Thus, the direct effects of MMP inhibition on survival following MI induction remains to be established. The present study was designed to address these issues by surgically inducing an MI in a large sample of mice, and performing a long term survival study (6 months) following treatment with a continuous MMP inhibition post-MI. LV structure and function were examined in the surviving mice in order to assess the effects of prolonged MMP inhibition in this murine post-MI model.
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Parke-Davis, MI) Pfizer, CT) or to remain untreated. Oral administration of this MMP inhibitor in animal models of LV remodeling have been described and characterized previously. (Ikonomidis et al., 2005; Mukherjee et al., 2003; Peterson et al., 2001; Spinale et al.,1999) The mice were coded by ear tag, and assigned in an alternating fashion to the MMP inhibitor or untreated groups. The treatment assignments and codes were not broken until the completion of the study. The dose of MMP inhibitor used in this study achieved a steady state plasma level of 8.5+ 2.2 mg/mL which has been demonstrated previously in ex-vivo studies to achieve a significant broad spectrum MMP inhibitory effect and has been used in rodents to achieve MMP µmol/L for MMP-9 to 0.008 µmol/L for MMP-13. (Peterson, 2001; Spinale, 1999) The plasma levels achieved in the present study significantly exceeded the EC 50 for all of the major MMP types by approximately 10-fold. In a past study, it has been demonstrated that this MMP inhibitor has a high myocardial penetrance and significantly inhibited myocardial MMP activity. (Mukherjee, 2003; Spinale, 1999) The rationale for initiating MMP inhibition at 3 days post-MI was 2-fold. First, this allowed for screening and confirmation of an MI in this murine model prior to treatment assignment. Second, the intent of this study was to examine post-MI remodeling and not to interfere with the acute phase of the myocardial wound healing process. The mice were examined in the morning and afternoon of each day. The duration of this study was 6 months.
LV Function, Histomorphometric and Biochemical Measurements at 6 Months
Terminal studies were performed in all of the surviving mice at 6 months. A cohort of age matched male mice (n=16) was included in these studies in order to serve as reference controls. LV function was first assessed by anesthetizing the mice as This article has not been copyedited and formatted. The final version may differ from this version.
JPET Fast Forward. Published on June 6, 2006 as DOI: 10.1124 at ASPET Journals on July 13, 2017 jpet.aspetjournals.org Downloaded from described in the previous section and 2-dimensional echocardiography performed in order to obtain LV end-diastolic volumes (µL) and ejection fraction (%) using conventional methods. (Collins et al., 2003) Following the echocardiographic study, and under 5% isoflurane, a sternotomy was performed and 0.5 mL of 0.1 mM cadmium chloride was injected into the LV in order to achieve mechanical arrest in diastole. The heart was quickly removed, placed in iced saline and the LV trimmed away and weighed. The LV was then divided into 2 equivalent sections along the long axis with transected the MI region. One LV section was then fixed in a 4% formalin solution overnight, embedded in paraffin and used for histomorphometrics. The second LV section was rapidly frozen in a dry ice slurry and maintained at -70degC until used for biochemical analysis.
For the histomorphometry studies, sections (5 µm) were stained with hematoxylin and eosin for measurement of MI size and myocyte  cross-sectional area using computer , 2003; Spinale et al., 1999; Yarbrough et al., 2003) In order to examine whether relative changes in MMP or TIMP profiles occurred in the treated and untreated MI groups at 6 months, substrate zymography was performed in order to assess the relative content of the gelatinases, MMP-2 and MMP-9. (Chapman 2003 et al.; Heymans et al., 1999; Peterson et al., 2001) Immunoblotting was performed for MMP-13 as well as for TIMP-1and -4 using methods described previously. (Ikonomidis et al., 2005; Mukherjee et al., 2003; Peterson et al., 2001 ;
This article has not been copyedited and formatted. The final version may differ from this version. were homogenized using ice-cold MMP extraction buffer (10mM cacodylic acid, 150mM NaCl, 0.01mM ZnCl 2 , 20mM CaCl 2 , 2mM NaN 3 , and 0.1% Triton-X-100, pH 5.0). For zymography, the myocardial homogenates (10 ug total protein) were subjected to electrophoretic separation containing a denatured collagen substrate (1 mg/mL type III gelatin, Sigma, St. Louis). For immunoblotting, myocardial extracts (10 µg) were loaded onto 4-12% BisTris gels and subjected to electrophoretic separation.
The separated proteins were then transferred to a nitrocellulose membrane. Following a blocking and washing step, the membranes were incubated for 1 hour in anti-sera 
Data Analysis
For the survival portion of the study, survival curves were constructed utilizing KaplanMeier probability estimates. The median survival time, that is the time at which 50% of the sample group died, was compared between the 2 groups utilizing a Chi-Square analysis. In addition, comparisons of survival were compared utilizing a stratified log rank test. LV function and geometry were compared between the 2 groups utilizing a t-test. For the morphometric data, the measurements of cross-sectional area and collagen area were first confirmed to conform to a Gaussian distribution, subjected to analysis of variance and finally to Tukey's test for mean separation. For the zymography and immunoblotting studies, all measurements were performed in duplicate, and the zymographic/immunoreactive signals were analyzed using densitometric methods (Gel Pro Analyzer, Media Cybernetics) to obtain 2-dimensional 
RESULTS
The constructed Kaplan-Meier post-MI survival curves for the 6 month observation period is shown in Figure 1 . The initiating time point (time 0) for was at the point of treatment assignment. Significant mortality occurred in the untreated, MI only group early in the follow-up period with a median survival of 5 days. However, median survival was 7-fold longer in the MI-MMPi group (Chi Square statistic:4.27, p<0.05). In the mice that survived for a longer duration, a much different effect was observed.
Specifically, the MI-MMPi survival curves crossed at approximately 45 days, and by 120 days the MMPi group demonstrated a significantly greater mortality compared to MI only (Chi Square statistic:9.71, p<0.05). Post-mortem analysis revealed that approximately 15% of the deaths were due to myocardial rupture at the LV apical region, 60% were due to occult cardiac decompensation as evidenced by significant serous fluid accumulation within the thoracic space, and 25% revealed no significant transudate or serosanginuous fluid in the thoracic space and therefore the deaths were presumed to be of a arrhythmic origin. There were no differences in these postmortem findings between treatment groups. Thus, an improvement in early post-MI survival was observed in the MMPi group, but with longer treatment durations a worsening survival occurred.
LV function and geometry by echocardiography were assessed in the mice surviving to 6 months in the MI only group (n=27) and the MI-MMPi group (n=17) and were compared to an age matched reference control group (n=16) The present study utilized a broad spectrum MMP inhibitor, defined as one that inhibits all major classes of MMPs. (Brinckerhoff and Matrisian, 2002; Coussens et al., 2002; McDonnell et al., 1999; Woessner, 1998) at ASPET Journals on July 13, 2017 jpet.aspetjournals.org Downloaded from
